|
US2021116526A1
|
|
Magnetic resonance imaging of neuro-electro-magnetic oscillations
|
|
WO2021067696A1
|
|
Antagonists of the muscarinic acetylcholine receptor m4
|
|
WO2021055428A1
|
|
Multi-articulated catheters with safety methods and systems for image-guided collaborative intravascular deployment
|
|
WO2021050829A1
|
|
Neuromodulation of the glossopharyngal nerve to improve sleep disordered breathing
|
|
US2021063717A1
|
|
Flat optics for image differentiation
|
|
WO2021046299A1
|
|
Methods for identification of antigen binding specificity of antibodies
|
|
WO2021042021A1
|
|
Human antibodies to alphaviruses
|
|
WO2021041788A1
|
|
Catalytic proton transport membranes and methods of making and use thereof
|
|
WO2021041466A1
|
|
Patient customized electro-neural interface models for model-based cochlear implant programming and applications of same
|
|
US2021049927A1
|
|
System, method and computer program product for determining a reading error distance metric
|
|
WO2021021951A1
|
|
Wdr5-myc inhibitors
|
|
WO2021021605A1
|
|
Human monoclonal antibodies to enterovirus d68
|
|
US2021011008A1
|
|
Amyloid-binding compounds and methods of use thereof
|
|
WO2020264475A1
|
|
Microfluidic systems, pumps, valves, fluidic chips thereof, and applications of same
|
|
WO2020264455A1
|
|
Bioreactor systems
|
|
WO2020264023A1
|
|
Determination of magnesium body concentration
|
|
WO2020252353A1
|
|
Amino acid transport inhibitors and the uses thereof
|
|
WO2020252336A1
|
|
Dibenzylamines as amino acid transport inhibitors
|
|
WO2020247679A1
|
|
Wdr5 inhibitors and modulators
|
|
US2020383938A1
|
|
Compounds and methods for scavenging dicarbonyl electrophiles
|
